Skip to main navigation
Skip to main content
KASL
Contact us
mobile search button
mobile menu button
Search
Advanced Search
ABOUT
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
ABOUT
Aims and scope
About the journal
Editorial board
Open access
Subscription information
Editorial board meeting
Contact us
BROWSE ARTICLES
All issues
Ahead-of-print
Current issue
Article category
Topics
Snapshot
Most viewed articles
Most downloaded articles
Most cited articles
Search
Video abstract
Metrics
FOR CONTRIBUTORS
Publish with
CMH
Instructions for authors
Peer review and publishing
Checklist
E-submission
Copyright transfer agreement
Page Path
HOME
Search
Treatment
WHERE t1.sid in(parameter_dbtbl_keyword '%Treatment%') and t1.xml_status <> 99
85
results for
"Treatment"
Filter
Article category
Review (21)
Original Article (12)
Editorial (5)
Guideline (3)
Correspondence (2)
More +
Keywords
Treatment (33)
Treatment outcome (18)
Hepatocellular carcinoma (13)
Chronic hepatitis B (12)
Diagnosis (10)
More +
Publication year
2025 (4)
2024 (5)
2023 (15)
2022 (2)
2021 (2)
More +
Article category
Review (21)
Original Article (12)
Editorial (5)
Guideline (3)
Correspondence (2)
Reply to Correspondence (1)
Snapshot (1)
Cancel
Close
Keywords
Treatment (33)
Treatment outcome (18)
Hepatocellular carcinoma (13)
Chronic hepatitis B (12)
Diagnosis (10)
prognosis (8)
Antiviral treatment (7)
Carcinoma, hepatocellular (6)
Entecavir (5)
Hepatitis B virus (5)
Survival (5)
Autoimmune hepatitis (4)
Hepatitis B (4)
Hepatitis B, chronic (4)
Treatment efficacy (4)
Epidemiology (3)
Guideline (3)
Hepatitis C virus (3)
Korea (3)
recurrence (3)
Surveillance (3)
Tenofovir (3)
Acute decompensation (2)
Adefovir (2)
Biomarkers (2)
Chronic Hepatitis C (2)
Clinical trials (2)
Drug resistance (2)
Drug resistance, viral (2)
Genotype (2)
Guidelines (2)
Hepatitis B core antigen (2)
Hepatitis B core-related antigen (2)
Human cytomegalovirus reactivation (2)
KASL guidelines (2)
Lamivudine (2)
NASH (2)
Neoplasm staging (2)
Non-alcoholic fatty liver disease (2)
Nonalcoholic fatty liver disease (2)
Nonalcoholic steatohepatitis (2)
Obesity (2)
Practice guideline (2)
Relapse (2)
Ribavirin (2)
Therapeutics (2)
Viremia (2)
Acute hepatic decompensation (1)
Adverse effect (1)
Adverse effects (1)
Alcohol (1)
alpha-fetoprotein (1)
Anti-diabetic drug (1)
antiangiogenics (1)
Antiviral agents (1)
Antiviral resistance (1)
Antiviral treatment-naïve (1)
Antivirals (1)
Artificial Liver Assist Devices (1)
Ascites (1)
Barcelona Clinic Liver Cancer (BCLC) (1)
Besifovir (1)
Bile duct invasion (1)
breakthrough (1)
Cardiovascular invasion (1)
China (1)
Cholangiocarcinoma (1)
Chronic hepatitis (1)
Chronic hepatitis C; Treatment; Direct-acting antivirals; Guidelines (1)
circulating tumor DNA (1)
Cirrhosis (1)
Clinical practice guideline (1)
Combination drug therapy (1)
Cost effectiveness (1)
cost-effectiveness analysis (1)
COVID-19 (1)
Cyanoacrylate (1)
Cytokine (1)
Diabetes mellitus (1)
Direct acting antivirals (1)
Direct-acting antivirals (1)
Disease management (1)
Disease progression (1)
drug (1)
Drug development in MASH (1)
Drugs (1)
External validation (1)
Fatty liver (1)
fibrosis regression (1)
Finite nucleos(t)ide analog therapy (1)
Gastric varices (1)
Grey-zone (1)
HCV (1)
Health insurance reimbursement (1)
Hemostasis, endoscopic (1)
